Skip to main content

U.S. Steel: Analysts' Upgrades, Downgrades

See who made what calls.
  • Author:
  • Publish date:

NEW YORK (TheStreet) -- CHANGE IN RATINGS

AK Steel (AKS) - Get AK Steel Holding Corporation Report upgraded at Citigroup from Hold to Buy. $21 price target. Company expects to see utilization rates grow, and should benefit from a more stable China steel market.

Ciena

(CIEN) - Get Ciena Corporation Report

rated new Buy at Citigroup. Acquisition of NT assets makes sense, especially with a low price tag. $17.50 price target.

Crane

(CR) - Get Crane Co. Report

upgraded at BofA Merrill. Rating raised to Neutral from Underperform. Price target raised to $32 from $22. 2009 EPS estimates raised to $2.13 from $1.92.

Edwards Lifesciences

(EW) - Get Edwards Lifesciences Corporation Report

upgraded at Goldman. $95 price target. Company has a new product cycle and the sales ramp should drive higher margins.

Nasdaq

I:IXIC

upgraded at Fox-Pitt from In-Line to Outperform. Estimates also raised, to reflect higher expected market share. $29 price target.

National Gas

(NFG) - Get National Fuel Gas Company Report

TheStreet Recommends

upgraded at Barclays to Equal Weight from Underweight. Shares now seen reaching $49, up from $35. 2009 and 2010 EPS estimates increased to $2.63 from $2.53 and to $2.45 from $2.43, respectively.

Nuvasive

(NUVA) - Get NuVasive, Inc. Report

downgraded at Goldman from Buy to Neutral. $45 price target. See limited upside to current earnings expectations, as core growth is slowing.

IMS Health

(RX)

downgraded at BofA Merrill. Rating lowered to Underperform from Neutral. Maintains $18 price target. Lowers 2009 EPS estimates to $1.60 from $1.65.

Sandisk

(SNDK)

downgraded at Goldman from Buy to Neutral. Valuation call, based on a $24 price target. See better upside potential in TXN.

Target

(TGT) - Get Target Corporation Report

upgraded at Citigroup from Sell to Buy. $61 price target. See significant earnings leverage, as same-store sales improve.

Texas Instruments

(TXN) - Get Texas Instruments Incorporated Report

upgraded at Goldman from Neutral to Buy. Market underestimates the ability to grow margins over the next several quarters. $29 price target.

Waters

(WAT) - Get Waters Corporation Report

numbers boosted at UBS. Shares of WAT now seen reaching $63. Estimates also raised, to reflect stable end markets and lower expenses. Neutral rating.

U.S. Steel

(X) - Get United States Steel Corporation Report

numbers lowered at Goldman. Shares of X now seen reaching $49. Estimates also cut, to reflect weakness in the flat rolled division. Buy rating.

STOCK COMMENTS / EPS CHANGES

Alcon

(ACL)

estimates, target increased at Citigroup. Estimates were raised through 2011. Company raised guidance for higher organic sales. Buy rating and new $155 price target.

Agco

(AGCO) - Get AGCO Corporation Report

estimates, target boosted at Goldman. Shares of AGCO now seen reaching $35. Estimates also increased, to reflect better cost controls and demand in South America. Neutral rating.

Apollo

(APOL)

estimate higher as Barclays. 2010 EPS estimates up by a penny to $5.20. Reiterate Overweight rating and $100 price target.

Avery Dennison

(AVY) - Get Avery Dennison Corporation Report

estimates boosted at UBS through 2010. Cost-cutting efforts are driving earnings higher. Sell rating and $30 price target.

BE Aerospace

(BEAV)

estimates, target increased at UBS. Shares of BEAV now seen reaching $20. Estimates were also raised, to reflect higher realized margins. Neutral rating.

Franklin Resources

(BEN) - Get Franklin Resources, Inc. Report

numbers raised at Citigroup. Shares of BEN now seen reaching $126. Estimates also increased, to reflect higher expected asset inflows. Buy rating.

Chicago Bridge

(CBI)

added to Conviction Buy list at Goldman Sachs. Estimates also raised, as the company has several catalysts that could boost margins. New $26 price target.

Cephalon

(CEPH)

estimates raised at Goldman through 2013. Company is seeing lower research and operating expenses. Buy rating and $67 price target.

Centene

(CNC) - Get Centene Corporation Report

estimates mixed at Credit Suisse. CNC 2009 EPS estimate increased by 2 cents to $1.95, 2010 cut by 2 cents to $2.10. Maintain Neutral rating and $22 price target.

Cabot Oil

(COG) - Get Cabot Oil & Gas Corporation Report

numbers increased at Goldman through 2011. Company boosted its production guidance and is realizing higher natural gas prices. Neutral rating and new $47 price target.

Capella

(CPLA) - Get Capella Education Company Report

price target, estimates increased at Credit Suisse. Price target raised to $68 from $65 after strong 3Q results. 2009 and 2010 EPS estimates boosted to $2.50 from $2.32 and to $3.22 from $3.00, respectively. Maintain Neutral rating.

Capella

(CPLA) - Get Capella Education Company Report

numbers raised at Morgan Stanley. Shares of CPLA now seen reaching $70. Estimates also boosted, to reflect higher enrollment growth and margin expectations. Equal-weight rating.

Crane

(CR) - Get Crane Co. Report

price target, estimates higher at Barclays. CR price target raised to $32 from $30. 2009 and 2010 EPS estimates lifted to $2.00 from $1.85 and to $2.15 from $1.90, respectively. Reiterate Equal Weight rating.

Commscope

(CTV) - Get Qwest Corp 6 7/8 % Notes 2014-1.10.54 Sr Report

numbers increased at UBS. Shares of CTV now seen reaching $30. Estimates also boosted, to reflect higher realized margins. Neutral rating.

Convergys

(CVG)

price target, estimates boosted at Credit Suisse. CVG price target lifted to $15 from $13. 2009 EPS estimate raised to $1.10 from $1.00, 2010 introduced at $1.25. Maintain Outperform rating.

Dreamworks

(DWA)

estimates boosted at UBS through 2010. Company is seeing lower expenses and tax rate, and 2010 should bring a better film slate. Neutral rating and $34 price target.

El Paso

(EP)

price target, estimates raised at Barclays. EP price target increased by a dollar to $13. Maintain Overweight rating. 2009 and 2010 EPS estimates increased to $1.08 and $1.24, respectively.

Exelon

(EXC) - Get Exelon Corporation Report

estimates, target boosted at Goldman. EXC estimates were raised through 2012. Company is cutting costs. Buy rating and new $64 price target.

FPL

(FPL) - Get First Trust New Opportunities MLP & Energy Fund Report

estimates, target reduced at Morgan Stanley. FPL estimates were cut through 2011. Rate case has been delayed, and the company lost some tax credits. Underweight rating and new $50.50 price target.

Nicor

undefined

price target, estimates increased at Barclays. GAS price target raised by a dollar to $38. 2009 and 2010 EPS estimates inflated to $2.61 and $2.97, respectively. Reiterate Underweight rating.

Harris

(HRS)

estimates, target boosted at UBS. HRS estimates were raised through 2011. Company seeing strong orders. Buy rating and new $47 price target.

Heidrick & Struggle

(HSII) - Get Heidrick & Struggles International, Inc. Report

price target, estimates boosted at Credit Suisse. HSII price target lifted to $26 from $20. 2009 and 2010 EPS estimates raised to -$0.25 and $0.50, respectively. Maintain Neutral rating.

Hexcel

(HXL) - Get Hexcel Corporation Report

estimates reduced at Goldman. HXL estimates were lowered through 2011. Company is seeing falling operating margins. Neutral rating and $13 price target.

InterActiveCorp

(IACI)

numbers boosted at Bernstein. Shares of IACI now seen reaching $23. Estimates were also raised, to reflect solid margin trends. Market Perform rating.

Illumina

(ILMN) - Get Illumina, Inc. Report

estimates lowered at UBS through 2010. Company is seeing order delays and was hurt by manufacturing issues. Buy rating and $45 price target.

Inverness Medical

(IMA)

numbers increased at UBS through 2010. Company is seeing higher flu sales and acquisitions are paying off. Buy rating and new $47 price target.

Johnson Controls

(JCI) - Get Johnson Controls International plc Report

numbers increased at Goldman. Shares of JCI now seen reaching $22. Estimates also boosted, to reflect a higher margin outlook. Sell rating.

Life Technologies

(LIFE) - Get aTyr Pharma, Inc. Report

numbers raised at UBS. Shares of LIFE now seen reaching $59. Estimates were also increased, to reflect higher flu sales and research demand. Buy rating.

L-3 Communications

(LLL) - Get JX Luxventure Limited Report

estimates boosted at Goldman through 2011. Company is seeing better growth, though relatively less than its peers. Should also benefit from a lower tax rate. Sell rating and $66 price target.

L-3 Communications

(LLL) - Get JX Luxventure Limited Report

target, estimates boosted at Barclays. Barclays raised LLL price target to $95 from $90 on strong 3Q, valuation. 2009 EPS estimate raised by a quarter to $7.50, 2010 lifted to $7.95 from $7.80. Maintain Overweight rating.

McKesson

(MCK) - Get McKesson Corporation Report

numbers boosted at Citigroup. Shares of MCK now seen reaching $77. Estimates also raised, to reflect a stronger flu season and cost cutting. Buy rating.

Molex

(MOLX)

estimates raised at Goldman through 2010. Better sales are driving higher margins and the company is also realizing a lower tax rate. Buy rating and $27 price target.

Norfolk Southern

(NSC) - Get Norfolk Southern Corporation Report

estimates boosted at Morgan Stanley through 2011. Company is cutting costs and management was positive about future price and volume trends. Equal-weight rating.

Norfolk Southern

(NSC) - Get Norfolk Southern Corporation Report

estimates raised at Barclays. NSC 2009 and 2010 EPS estimate up to $2.77 and $3.70, respectively. Maintain Equal Weight rating and $51 price target.

Paccar

(PCAR) - Get PACCAR Inc Report

estimates lowered at Goldman through 2010. Company is seeing higher operating costs. Neutral rating and $38 price target.

RF Micro

(RFMD)

estimates boosted at Morgan Stanley through 2011. Strong relationships with NOK and Samsung are helping to drive growth. Underweight rating.

RF Micro Devices

(RFMD)

price target, estimates boosted at Barclays. RFMD shares now seen reaching $5.50. 2010 and 2011 EPS estimates raised to $0.40 and $0.45, respectively. Reiterate Equal Weight price target.

Schnitzer Steel

(SCHN) - Get Schnitzer Steel Industries, Inc. Class A Report

numbers reduced at Goldman. SCHN estimates were cut through 2012. Margins are down in the metal recycling business, because of higher competition. Sell rating and new $40 price target.

Suntrust Banks

(STI) - Get SunTrust Banks, Inc. Report

added to Top Picks list at Citigroup. $28 price target. Stock appears oversold, relative to its risks to commercial real estate and construction. Buy rating.

Textron

(TXT) - Get Textron Inc. Report

estimates reduced at Goldman through 2010. Company facing higher restructuring costs and dilution from the recent convertible offering. Buy rating and $25 price target.

Visa

(V) - Get Visa Inc. Class A Report

price target raised at Barclays to $84 from $75 on belief that comps will turn positive in 4Q. 2010 EPS estimate set at $3.50. Maintain Equal Weight rating.

Visa

(V) - Get Visa Inc. Class A Report

target raised at Citigroup. Shares of V now seen reaching $80. Company is positioned well to benefit from a recovery in U.S. spending. Hold rating.

Williams

(WMB) - Get Williams Companies, Inc. Report

price target, estimates changed at Barclays. Price target up to $22 from $20. 2009 EPS estimate raised to $0.96, 2010 cut to $1.42. Maintain Overweight rating.

This article was written by a staff member of TheStreet.com.